NCT02140346 A Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Repeat Doses of RV1729 for 28 Days in Patients With COPD Status COMPLETED Phase PHASE1
NCT02136875 Strategy for Early Treatment of Exacerbations in COPD: Standing Prescriptions of Advair With a Written Action Plan in the Event of an Exacerbation Status COMPLETED Phase PHASE4
NCT02135744 Pre-Discharge Bundle for Patients With Acute Exacerbations of Chronic Obstructive Pulmonary Disease to Reduce Readmissions Status COMPLETED Phase NA
NCT02135354 Azithromycin for Acute Exacerbations Requiring Hospitalization Status TERMINATED Phase PHASE3
NCT02128529 Epidemiology of Chronic Bronchitis in Patients With Chronic Obstructive Pulmonary Disease (COPD) Status COMPLETED Phase N/A
NCT02125734 Lung Function and Patient Preference With QVA149 vs. Tiotropium in COPD Patients Status COMPLETED Phase PHASE4
NCT02123199 Study of the Impact of Indacaterol (Onbrez®) on the Individual Lives and Health Status of Patients With COPD Status COMPLETED Phase N/A
NCT02109172 A 7-Day Cross-over Study of QD (Once Daily) and BID (Twice Daily) TD-4208 in Chronic Obstructive Pulmonary Disease (COPD) Status COMPLETED Phase PHASE2
NCT02108925 Effect of Oxygen Supplementation During Exercise in Chronic Obstructive Pulmonary Disease Patients Status COMPLETED Phase NA
NCT02107222 The PALP™-COPD Trial (Low-Flow CO2-Removal (ECCO2-R) in Exacerbated COPD) Status WITHDRAWN Phase NA
NCT02100709 The Effect of NIV on QoL and Exercise Capacity in a COPD Exercise Rehabilitation Program Status TERMINATED Phase NA
NCT02100332 A Cross Sectional Disease/Condition Focused Observational Study on Chronic Obstructive Pulmonary Disease (COPD) Status COMPLETED Phase N/A
NCT02092675 Endothelial Dysfunction and Chronic Obstructive Pulmonary Disease Status COMPLETED Phase N/A